Jung Ho Hyun | Neuronal Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Jung Ho Hyun | Neuronal Cell Biology | Best Researcher Award

Dr. Jung Ho Hyun , Daegu Gyeongbuk Institute of Science & Technology (DGIST) , South Korea

Dr. Jung Ho Hyun is an Assistant Professor at the Department of Brain Sciences, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Korea. His research focuses on neurophysiology, cognitive neuroscience, and molecular tools for studying neural activity. He earned his Ph.D. in Physiology from Seoul National University (SNU) in 2015, after completing a Master’s in the same field at SNU. Dr. Hyun’s academic career includes significant research experience at prestigious institutions, including Johns Hopkins University and the Max Planck Florida Institute for Neuroscience. His work has led to important insights into memory, cognitive flexibility, and neuronal activity. Dr. Hyun is dedicated to mentoring young scientists and sharing his knowledge through invited lectures worldwide. His contributions to neuroscience have made a significant impact, evidenced by numerous publications in renowned journals.

Publication Profile: 

Google Scholar

Strengths for the Award:

Dr. Jung Ho Hyun is a highly accomplished and innovative researcher with significant contributions to the field of neuroscience, particularly in understanding neuronal activity and cognitive processes. His research focuses on cutting-edge topics such as memory, cognitive flexibility, and the development of molecular tools for neuronal manipulation. His ability to integrate molecular biology with neurophysiology has advanced the scientific community’s understanding of brain function, making his work highly relevant for both basic science and clinical applications. Dr. Hyun’s leadership and mentoring roles have also fostered future generations of neuroscientists, further solidifying his impact in the field.

Notable accomplishments include several prestigious awards and travel grants, invited lectures at international conferences, and a strong publication record in high-impact journals such as Nature Communications and The Journal of Physiology. His involvement in interdisciplinary research and development of novel techniques for manipulating neural circuits positions him as a leading figure in his field.

Areas for Improvement:

While Dr. Hyun has demonstrated tremendous research capabilities, one area for growth could be expanding his research collaborations to interdisciplinary fields such as computational neuroscience, which may further enhance the translation of his findings to clinical and therapeutic applications. In addition, as his work continues to gain prominence, a greater focus on the application of his research to the treatment of neurological diseases could increase the broader societal impact of his work.

Education:

Dr. Jung Ho Hyun completed his Bachelor’s degree in Biology from Pusan National University, South Korea, in 2007. He then pursued graduate studies at Seoul National University (SNU) College of Medicine, earning his Master of Science (M.Sc.) in Physiology in 2010. Following this, he continued his research journey and obtained a Ph.D. in Physiology from SNU in 2015 under the supervision of Dr. Suk-Ho Lee. Dr. Hyun’s strong academic foundation provided him with the tools to delve deeply into neurophysiology and molecular neuroscience. His educational journey has led to groundbreaking research at the intersection of memory, neuronal activity, and cognitive behavior. He has continuously built on his academic foundation with collaborative research experiences at leading global institutions such as Johns Hopkins University and the Max Planck Florida Institute for Neuroscience.

Experience:

Dr. Jung Ho Hyun currently serves as an Assistant Professor at the Department of Brain Sciences at Daegu Gyeongbuk Institute of Science and Technology (DGIST), South Korea. Prior to this, he was a JHU Research Fellow at Johns Hopkins University School of Medicine, where he contributed to important projects on cognitive neuroscience and neuronal activity. Dr. Hyun has also been involved in significant research activities at the Max Planck Florida Institute for Neuroscience. His primary research focus includes molecular tools for recording and manipulating neuronal activity, and understanding the molecular underpinnings of cognitive flexibility. In his academic career, he has not only contributed to cutting-edge research but has also been an educator, lecturing on human physiology and neuroimaging techniques. As a mentor, Dr. Hyun has guided students and researchers, cultivating future scientists in the field of neuroscience.

Awards and Honors:

Dr. Jung Ho Hyun has received numerous prestigious awards throughout his career. In 2021, he was awarded the Travel Award at the 44th Annual Meeting of the Japan Neuroscience Society. His work has also been recognized with the 2019 Gill Symposium Travel Award, which supported his research contributions at a global level. In 2018, he received the Korean American Society in Biotech and Pharmaceuticals Fellowship Award, recognizing his outstanding research contributions in the field of neuroscience. Dr. Hyun was also granted the Max Planck Florida Institute for Neuroscience (MPFI) Travel Grant in 2018, facilitating further academic collaborations. These honors reflect the recognition and respect Dr. Hyun has earned within the scientific community, underscoring his commitment to advancing neuroscience research. His consistent pursuit of excellence is further exemplified by his leadership in mentoring and scientific outreach efforts.

Research Focus:

Dr. Jung Ho Hyun’s research focuses on understanding the neural mechanisms underlying cognitive flexibility, memory, and complex behavioral processes. His work explores how memory is stored and retrieved in the brain and how neural circuits contribute to cognitive processes such as decision-making and behavioral flexibility. Dr. Hyun’s lab utilizes molecular tools, including genetically encoded calcium indicators, to track and manipulate neuronal activity at the cellular and circuit level. One of his key areas of focus is understanding how neural populations encode and process information, particularly in regions like the orbitofrontal cortex. His research aims to uncover how manipulating neural ensembles can help treat brain illnesses and disorders. Dr. Hyun’s contributions to the development of new methods to study neural activity have positioned him at the forefront of neurophysiological research, with significant potential for clinical applications.

Publications Top Notes:

  1. Eom K#, Kim D#, Hyun JH* (2025) “Engram and behavior: How memory is stored in the brain.” 🧠📚 Neurobiology of Learning and Memory.
  2. Eom K, Jung J#, Kim B#, Hyun JH* (2024) “Molecular tools for recording and intervention of neuronal activity.” 🧬🔬 Molecules and Cells.
  3. Hyun JH, Hannan P, Iwamoto H, Blakely R, Kwon H-B (2023) “Serotonin in the orbitofrontal cortex enhances cognitive flexibility.” 🧠💡 bioRxiv.
  4. Hyun JH#, Nagahama K#, Ho N#, Mignocchi N, Roh S-E, Hannan P, Krüssel S, Kwak C, McElroy A, Liu B, Cui M, Lee S, Lee D, Huganir RL, Worley PF, Sawa A, Kwon H-B (2022) “Tagging active neurons by soma-targeted Cal-Light.” 🔦🧬 Nature Communications.
  5. Eom K#, Lee HR#, Hyun JH, Ryu H-H, Lee Y-S, Ho W-K, Lee S-H (2021) “Gradual decorrelation of CA3 ensembles associated with contextual discrimination learning is impaired by Kv1.2 insufficiency.” 🔬📊 Hippocampus.

Conclusion:

Dr. Jung Ho Hyun is an excellent candidate for the Best Researcher Award due to his innovative research, exceptional contributions to neuroscience, and strong leadership. His multidisciplinary approach to understanding cognitive flexibility and memory, along with his pioneering use of molecular tools to study neural circuits, sets him apart as a leader in his field.

Fucheng Lin | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Fucheng Lin | Microbial Cell Biology | Best Researcher Award

Prof. Fucheng Lin , Zhejiang Academy of Agricultural Sciences (ZAAS) , China

Lin Fu-Cheng is a distinguished professor and president at the Zhejiang Academy of Agricultural Sciences, specializing in the prevention and control of plant fungal diseases. His groundbreaking research on the pathogenic mechanisms of fungi, immune systemic resistance in plants, and the development of disease-resistant crops has earned him numerous accolades, including the prestigious National Science Fund for Distinguished Young Scholars. With over 13,000 citations, he is a leading figure in agricultural science. He has contributed significantly to the understanding of plant fungal diseases, with notable innovations in disease-resistant germplasm and sustainable agricultural practices. He holds several important editorial roles, including as chief editor for prominent journals. Lin Fu-Cheng’s collaborative efforts in research have positioned him as a key scientist in various national and international agricultural research projects.

Publication Profile: 

Orcid

Strengths for the Award:

  1. Outstanding Research Contributions:

    • Lin Fu-Cheng has made groundbreaking contributions in the field of plant pathology, especially in understanding the pathogenic mechanisms of plant fungal diseases. His pioneering work on the relationship between autophagy and pathogenicity in Magnaporthe oryzae has opened new avenues for research on plant pathogenic fungi.
    • His establishment of a novel evolutionary model between endophytic fungi, pathogenic fungi, and plants has furthered sustainable disease management strategies, especially for rice blast, a major threat to rice production globally.
    • Fu-Cheng has creatively integrated interspecific hybridization techniques to create disease-resistant germplasm, enhancing agricultural sustainability.

  2. Innovative Approach to Disease Control:

    • His work using endophytic fungi to induce immunity in rice represents a shift toward environmentally sustainable disease management practices. This innovative strategy offers a promising alternative to chemical-based interventions and aligns with the global push for green agricultural development.

  3. Recognition and Impact:

    • With more than 13,000 citations and over 280 published papers in high-impact journals, Fu-Cheng’s research has had a significant influence on the scientific community. His citation index of over 10,000 demonstrates the global recognition of his work.
    • He has led several major research projects, including national and provincial projects focused on agricultural technology, demonstrating his leadership and expertise.

  4. Leadership and Mentorship:

    • As a professor and doctoral supervisor, Fu-Cheng has mentored numerous students, many of whom are actively contributing to research in related fields. His leadership roles in both national and international scientific organizations further solidify his stature in the research community.

  5. High-Impact Publications and Patents:

    • Fu-Cheng has published over 195 SCI papers and holds 141 patents, many of which have been applied industrially. His contributions to both the academic and practical sides of plant protection are noteworthy.

Areas for Improvement:

  1. Broader Collaboration Across Disciplines:

    • While Fu-Cheng has demonstrated exceptional leadership in his field, expanding collaborations with researchers from other disciplines, such as environmental science and agronomy, could further enhance the applicability and scope of his research in global agricultural practices.

  2. Global Outreach and Dissemination:

    • Though Fu-Cheng’s research is highly impactful, increased visibility in global agricultural policy-making circles could ensure his innovative solutions reach a broader audience. Collaborating with international organizations and policymakers could facilitate the adoption of his findings on a larger scale, particularly in regions most affected by rice blast.

  3. Integration of Climate Change Research:

    • Given the ongoing challenges posed by climate change to agricultural productivity, Fu-Cheng’s future research could benefit from focusing on how climate factors influence the pathogenicity of plant diseases, especially in the context of shifting agricultural practices.

Education:

Lin Fu-Cheng earned his Ph.D. in Plant Pathology and Microbiology from Zhejiang University, China. Over the years, his academic training and postdoctoral research have helped shape his expertise in plant disease control and fungal pathology. As a doctoral supervisor, he has mentored numerous students, guiding them in the realms of agricultural science, plant protection, and microbiology. His rigorous academic foundation in both theoretical research and applied science has laid the groundwork for his leadership in significant projects related to the management of biotic threats to agro-product safety. Lin’s educational journey also involved extensive international collaboration, which broadened his scientific perspectives and fostered a strong commitment to advancing agricultural technology on a global scale.

Experience:

Lin Fu-Cheng is a seasoned academic and research leader with over two decades of experience in the field of plant protection and microbiology. He has presided over numerous high-impact research projects, including national and provincial funding programs. His leadership as the chief scientist in national key research and development programs has contributed substantially to the development of new methodologies for managing plant diseases, particularly fungal pathogens. Lin has been instrumental in bridging academia and industry through his involvement in over 17 consultancy and industry-related projects. His work on the development of disease-resistant crops and innovative agricultural practices has gained widespread recognition. He has also contributed significantly to various scientific journals, where his editorial roles have allowed him to shape the direction of research in plant pathology. Lin’s vast experience in managing large-scale research initiatives has made him a respected figure in agricultural sciences both in China and internationally.

Research Focus:

Lin Fu-Cheng’s research focuses on plant fungal diseases, with a particular emphasis on the pathogenic mechanisms of fungi, immunity induction by endophytic fungi, and the creation of disease-resistant crops. His pioneering work on autophagy in Magnaporthe oryzae has opened new avenues in understanding fungal pathogenicity. He established a groundbreaking model for the interaction between endophytic fungi, pathogenic fungi, and plants, which provides insights into sustainable disease management practices. Additionally, Lin has combined interspecific hybridization with disease-resistant germplasm innovation, contributing to the development of crops that are more resilient to fungal diseases. His research integrates both theoretical studies and practical applications, aimed at enhancing agricultural productivity and promoting the green development of agriculture. With his vast contributions to plant protection, Lin is at the forefront of research that seeks to mitigate the impact of plant diseases on global food security.

Publication Top Notes:

  • A glance at structural biology in advancing rice blast fungus research 🧬
  • A key sphingolipid pathway gene, MoDES1, regulates conidiation, virulence, and plasma membrane tension in Magnaporthe oryzae 🌱
  • A pair of nuclear factor Y transcription factors act as positive regulators in jasmonate signaling and disease resistance in Arabidopsis 🌾
  • A repressive H3K36me2 reader mediates Polycomb silencing 🔬
  • A rho-type GTPase activating protein affects the growth and development of Cordyceps cicadae 🍄
  • A Taxonomic Study of Candolleomyces Specimens from China Revealed Seven New Species 🌿
  • Actin-related protein MoFim1 modulated the pathogenicity of Magnaporthe oryzae by controlling three MAPK signaling pathways, appressorium formation, and hydrophobicity 🧪
  • Cand2 inhibits CRL-mediated ubiquitination and suppresses autophagy to facilitate pathogenicity of phytopathogenic fungi 💡
  • Csn5 inhibits autophagy by regulating the ubiquitination of Atg6 and Tor to mediate the pathogenicity of Magnaporthe oryzae 🦠
  • DGK5 6-derived phosphatidic acid regulates ROS production in plant immunity by stabilizing NADPH oxidase 🌟

Conclusion:

Lin Fu-Cheng’s achievements in plant pathology are not only groundbreaking but also have significant practical implications for sustainable agricultural practices. His research has laid the foundation for innovative disease management strategies, and his work on autophagy, endophytic fungi, and disease-resistant germplasm is leading the way toward more eco-friendly agricultural solutions. His strong academic record, leadership, and contributions to the field make him a highly deserving candidate for the Best Researcher Award. Expanding his collaborations and outreach efforts could further amplify his impact on global agricultural sustainability.

Sheng-Chi Hsu | molecular diagnosis | Best Researcher Award

Published on by Cell Biologist

Mrs. Sheng-Chi Hsu | molecular diagnosis | Best Researcher Award

Mrs. Sheng-Chi Hsu , Department of Laboratory Medicaine, Chang Gung Memorial Hospital at LinKou , Taiwan

Sheng-Chi Hsu, M.S., is a leading expert in tumor biology, molecular pathology, and personalized medicine. Currently serving as the Deputy Director of the Department of Laboratory Medicine at Chang Gung Memorial Hospital, Linkou Branch, he has extensive experience in cancer diagnostics, molecular pathology, and clinical research. With a strong academic background and a commitment to advancing medical science, Hsu has contributed significantly to the field of oncology, focusing on novel diagnostic approaches and precision medicine strategies. His research has resulted in several impactful publications, enhancing diagnostic accuracy and the development of targeted therapies for various cancers. Hsu’s work has played a pivotal role in improving patient outcomes and shaping the future of cancer treatment in Taiwan.

Publication Profile: 

Scopus

Strengths for the Award:

Sheng-Chi Hsu has demonstrated exceptional expertise in tumor biology, molecular pathology, and personalized medicine, contributing to groundbreaking advancements in cancer diagnostics and precision medicine. His leadership roles at Chang Gung Memorial Hospital, particularly in the Department of Laboratory Medicine and Pathology, showcase his ability to manage large teams and oversee complex laboratory operations while pushing the boundaries of research. His publications in prestigious journals highlight significant research achievements, including the identification of key biomarkers for cancer therapies and advancing molecular diagnostic techniques. Hsu’s research on cancer biomarkers, including ALK translocation and ROS1 translocation in non-small cell lung cancer (NSCLC), has provided valuable insights into targeted therapies, which are directly influencing patient care and therapeutic approaches. His work on multidrug resistance also opens new therapeutic avenues to overcome chemotherapy resistance, making his contributions pivotal to modern cancer treatment strategies.

Areas for Improvements:

While Hsu’s research accomplishments are impressive, expanding his involvement in large-scale, multi-center clinical trials could further enhance the real-world application and validation of his research findings. Collaborating with international institutions or expanding his research scope to include more diverse populations may also increase the generalizability and impact of his findings. Additionally, although Hsu has an extensive background in molecular diagnostics, there may be room to explore emerging technologies, such as artificial intelligence in pathology, to further optimize diagnostic procedures and improve precision medicine outcomes.

Experience:

Sheng-Chi Hsu has over 15 years of experience in laboratory medicine and pathology, with expertise in tumor pathology and molecular diagnostics. He is currently the Deputy Director of the Department of Laboratory Medicine at Chang Gung Memorial Hospital, where he leads research and development in laboratory diagnostics. Previously, he served as the Deputy Director of the Department of Pathology, overseeing innovations in histopathological diagnostics. Hsu’s leadership has been instrumental in advancing cancer diagnostics, optimizing molecular diagnostic techniques, and improving laboratory workflows. His career also includes roles as a Chief and Senior Medical Technologist, where he pioneered research in tumor pathology, focusing on biomarker identification and the development of diagnostic assays.

Research Focus:

Sheng-Chi Hsu’s research focuses on advancing molecular diagnostics, particularly in oncology. His work aims to enhance diagnostic precision for various cancers, with a strong emphasis on personalized medicine. Hsu has made significant contributions to the genetic characterization of tumors, identifying key biomarkers for targeted therapies in non-small cell lung cancer (NSCLC), synovial sarcoma, and gestational trophoblastic disease. His research in multidrug resistance mechanisms and the role of Wnt5A in cancer therapy has opened new avenues for overcoming chemoresistance. Hsu’s pioneering studies in molecular pathology have significantly impacted clinical practices, helping improve treatment strategies and patient outcomes through advanced diagnostics.

Publications Top Notes:

  1. Wang HS, Liu CY, Hsu SC, Huang SC, Hung TH, Ng KF, Chen TC. A Single-Institute Experience with C-ros Oncogene 1 Translocation in Non-Small Cell Lung Cancers in Taiwan. Int J Mol Sci. 2022 May 21;23(10):5789. 📄
  2. Hsu SC, Hung TH, Wang CW, Ng KF, Chen TC. Anaplastic lymphoma kinase translocation is correlated with anaplastic lymphoma kinase expression and mutually exclusive with epidermal growth factor receptor mutation in Taiwanese non-small cell lung cancer. Pathol Int. 2015 May;65(5):231-9. 📄
  3. Hung TH, Hsu SC, Cheng CY, Choo KB, Tseng CP, Chen TC, Lan YW, Huang TT, Lai HC, Chen CM, Chong KY. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway. Oncotarget. 2014 Dec 15;5(23):12273-90. 📄
  4. Chen KH, Hsu SC, Chen HY, Ng KF, Chen TC. Utility of fluorescence in situ hybridization for ploidy and p57 immunostaining in discriminating hydatidiform moles. Biochem Biophys Res Commun. 2014 Apr 4;446(2):555-60. 📄
  5. Chuang HC, Hsu SC, Huang CG, Hsueh S, Ng KF, Chen TC. Reappraisal of TLE-1 immunohistochemical staining and molecular detection of SS18-SSX fusion transcripts for synovial sarcoma. Pathol Int. 2013 Dec;63(12):573-80. 📄

Conclusion:

Sheng-Chi Hsu is highly deserving of the “Best Researcher Award” due to his outstanding contributions to cancer research and diagnostic advancements. His innovative approach to tumor pathology and molecular diagnostics, along with his leadership in clinical and research operations, makes him a transformative figure in the field. With a continued focus on expanding his research scope and incorporating emerging technologies, Hsu’s impact on personalized cancer treatments is poised to grow even further.

Anming Meng | Developmental Cell Biology | Best Researcher Award |

Published on by Cell Biologist

Prof. Anming Meng | Developmental Cell Biology | Best Researcher Award

Prof. Anming Meng  , School of Life Sciences, Tsinghua University , China

Anming Meng (孟安明), born on July 22, 1963, in Dazhu County, Sichuan, China, is a renowned developmental biologist. With a bachelor’s degree in agronomy from Southwest Agricultural University in 1983, he began his career in rice breeding before shifting focus to genetics. He earned his Ph.D. in 1991 from the University of Nottingham, UK. Meng’s groundbreaking research in zebrafish embryogenesis, initiated in 1996, led to significant advancements in developmental biology. A full professor at Tsinghua University since 1998, he has contributed immensely to understanding gene regulation, cell fate, and patterning in vertebrate embryos. Meng is a member of the Chinese Academy of Sciences and TWAS, serving on various editorial boards and scientific societies. His influence is widespread, with many of his former trainees holding prominent positions in research institutions worldwide.

Publication Profile: 

Orcid

Strengths for the Award:

  1. Pioneering Research Contributions:

    • Anming Meng is a trailblazer in the field of developmental biology, particularly with his work on zebrafish embryogenesis. He has made groundbreaking discoveries, such as the identification of region-specific expression genes in zebrafish embryos and the functional roles of signaling pathways in early vertebrate development.
    • His discovery of the role of Huluwa in activating β-catenin signaling for embryonic organizer and body axis formation resolved a long-standing question in the field of developmental biology. This work has had a significant impact on our understanding of embryonic development in vertebrates.

  2. Innovative Use of Model Systems:

    • Dr. Meng’s lab was the first to establish a zebrafish lab in China, making significant contributions to the understanding of gene regulation, cell fate determination, and the mechanisms driving early embryonic development. His use of zebrafish as a model system to study these processes has been highly influential.

  3. Consistent Leadership in Research and Mentorship:

    • As a mentor, he has trained many successful researchers who now hold prominent academic and research positions worldwide. His commitment to fostering future scientific leaders is commendable, and his students have contributed significantly to developmental biology and related fields.

  4. High Impact Publications and Academic Service:

    • Dr. Meng has published numerous high-impact articles in prestigious journals, contributing to advancements in our understanding of developmental biology. Furthermore, he has played an active role in editorial boards and advisory positions, demonstrating leadership in the scientific community.
    • His role in academic societies, such as his presidency of the China Zoological Society and his contributions to the Genetics Society of China, further demonstrates his influence and commitment to advancing science in China and globally.

  5. Awards and Recognition:

    • Dr. Meng has received several prestigious awards, including the Outstanding Young Scholar Award from the Hong Kong Qiu Shi Science & Technologies Foundation and the Lifetime Accomplishment Award in Zebrafish Research. These accolades underscore the widespread recognition of his contributions to the field of developmental biology.

Areas for Improvement:

  1. Collaborative Interdisciplinary Research:

    • While Anming Meng’s work is exceptional in the domain of developmental biology, there could be more collaborative efforts with researchers from other disciplines like bioinformatics, computational biology, and material science. This could accelerate the integration of cutting-edge technologies, such as AI and CRISPR/Cas9, into his research and broaden the scope of his investigations into complex biological systems.

  2. Expanding Global Research Impact:

    • While his lab has made significant strides in the field, increasing the global outreach of his work could further elevate his contributions. This could involve more international collaborations, especially in regions where zebrafish research is in the earlier stages, as well as increasing visibility at global conferences and through open-access publications.

  3. Public Engagement and Science Communication:

    • As a leader in the field, Anming Meng could expand his impact by focusing more on science communication to a broader audience. Engaging with the public through outreach programs, online platforms, or educational content could help translate complex research into more accessible knowledge for society at large.

Education:

Anming Meng completed his undergraduate studies in 1983 at Southwest Agricultural University (now part of Southwest University), where he earned a bachelor’s degree in agronomy. His initial research focused on rice breeding. In 1987, he pursued graduate studies at the University of Nottingham, UK, under Dr. David T. Parkin, concentrating on genetic variation in wild birds using DNA fingerprinting. He earned his Ph.D. in 1991. Following this, he worked as a postdoctoral researcher at Beijing Agricultural University (now China Agricultural University), specializing in DNA fingerprinting of farm animals. Meng continued his academic journey in the U.S. as a visiting scholar at the Medical College of Georgia in 1996, working on zebrafish embryonic development in Dr. Shuo Lin’s lab. In 1998, he joined Tsinghua University as a full professor and later became a prominent figure in Chinese developmental biology.

Experience:

Anming Meng has an extensive career in both research and academia. He began as a research assistant at the National Rice Research Institute of China, before pursuing graduate studies in the UK under Dr. David T. Parkin. After earning his Ph.D. in 1991, he joined Beijing Agricultural University as a postdoctoral researcher, where he worked on DNA fingerprinting of farm animals. Meng’s pivotal shift toward zebrafish embryogenesis began in 1996 when he joined Dr. Shuo Lin’s lab at the Medical College of Georgia, USA, as a visiting scholar. In 1998, he was recruited as a full professor at Tsinghua University, where he established the first zebrafish lab in China. Over the years, Meng has led research on vertebrate embryonic development, with notable work on gene regulation and signaling pathways. He has mentored numerous successful graduates who have taken leading positions in research institutions across the globe.

Awards and Honors:

Anming Meng has received numerous prestigious awards and honors for his contributions to developmental biology. In 2000, he was named an Outstanding Young Scholar by the Hong Kong Qiu Shi Science & Technologies Foundation and received the Teaching and Research Award for University Outstanding Young Teachers from the Ministry of Education of China. Meng also won the China National Funds for Distinguished Young Scholars in 2000. He was awarded the Cheung Kong Scholar title by the Ministry of Education of China and Li Ka Shing Foundation in 2001. In 2007, he received the Ho Leung Ho Lee Foundation Prize for Science and Technology Advancement. Later awards include the Tan Jia Zhen Achievement Award in Life Sciences in 2012, the Outstanding Accomplishment Award from the Chinese Society of Cell Biology in 2020, and the Lifetime Accomplishment Award in Zebrafish Research in 2023, recognizing his remarkable impact on the field.

Research Focus:

Anming Meng’s research primarily focuses on developmental biology, with a special emphasis on zebrafish embryogenesis. His work has explored the molecular mechanisms regulating cell fate and early vertebrate patterning. Notably, he and his team have made groundbreaking discoveries in gene regulation, identifying essential signaling pathways involved in mesendoderm induction, dorsoventral patterning, and left-right asymmetry during zebrafish development. Meng’s lab pioneered the use of GFP reporters for live imaging of gene expression, contributing significantly to the study of genetic regulation in living organisms. His team also uncovered a key role for the maternal protein Huluwa in activating β-catenin signaling during embryonic axis formation, solving a longstanding question in the field. Recently, his lab’s focus has expanded to the nuclear pore complex’s clock-like function in zygotic genome activation and the role of the second polar body in mouse embryo development. Meng’s work continues to drive significant advancements in developmental and molecular biology.

Publications Top Notes:

  1. “Mapping the chromatin accessibility landscape of zebrafish embryogenesis at single-cell resolution by SPATAC-seq” 🧬🔬
  2. “Repression of MAPK/Erk signaling by Efnb2-Ephb4-Rasa1 is required for lymphatic valve formation” 💉🧪
  3. “A Golgi-derived vesicle potentiates PtdIns4P to PtdIns3P conversion for endosome fission” 📦🧫
  4. “TGFβ family signaling and development” 🧫🧬
  5. “Systematic genome editing of the genes on zebrafish Chromosome 1 by CRISPR/Cas9” 🧬🔧
  6. “Mini-III RNase-based dual-color system for in vivo mRNA tracking” 🧬💡
  7. “Sec14l3 potentiates VEGFR2 signaling to regulate zebrafish vasculogenesis” 🌱🧬
  8. “Migrasomes provide regional cues for organ morphogenesis during zebrafish gastrulation” 🧫🧠
  9. “RNA 5-Methylcytosine Facilitates the Maternal-to-Zygotic Transition by Preventing Maternal mRNA Decay” 🧬💉

Conclusion:

Anming Meng is undoubtedly a highly deserving candidate for the Best Researcher Award due to his pioneering research in developmental biology, particularly in the use of zebrafish as a model organism. His contributions have advanced our understanding of gene regulation, embryonic development, and the molecular mechanisms governing cell fate determination. As a leader, mentor, and active member of the scientific community, Dr. Meng has not only advanced the field but also nurtured the next generation of researchers. While there are areas for improvement, especially in terms of expanding collaborative efforts and public engagement, his exceptional body of work, recognition from prestigious institutions, and commitment to advancing science make him an ideal candidate for this prestigious award.

Waseem Haider | Bioinformatics | Best Paper Award

Published on by Cell Biologist

Dr. Waseem Haider | Bioinformatics | Best Paper Award

Dr. Waseem Haider , COMSATS University Islamabad , Pakistan

Dr. Waseem Haider is an Associate Professor of Bioinformatics at COMSATS University Islamabad, Pakistan, with over 25 years of teaching and research experience. He holds a Ph.D. from the University of Illinois at Urbana-Champaign, USA. As the founder and CEO of Next Gen. Solutions, a data analysis training and consultation company, he has trained over 1500 researchers in various fields, including DNA/RNA sequencing, public health data analysis, and machine learning applications. Dr. Haider’s expertise spans bioinformatics, molecular biology, and data science, utilizing tools such as R, SAS, Python, and PERL. His significant contributions include high-impact research on genetic analysis, disease monitoring, and agricultural genomics. He is passionate about applying computational methods to solve complex biological problems, enhancing public health, and advancing biotechnology.

Publication Profile:

Orcid

Strengths for the Award:

  1. Impressive Academic and Research Track Record: Dr. Haider has a wealth of experience in teaching, supervising graduate and postgraduate research, and contributing significantly to the field of bioinformatics. His supervision of over 25 MS theses and 4 PhD candidates speaks to his leadership in academic research.

  2. Wide Range of Research Interests: His research interests are diverse, covering plant biology, molecular genetics, disease diagnostics, and public health. This breadth shows that Dr. Haider is not only an expert in bioinformatics but also contributes substantially to real-world challenges in genomics and medicine.

  3. High-Impact Publications: Dr. Haider has co-authored numerous publications in reputed international journals, including high-impact ones such as PLoS One, Frontiers in Plant Science, Plant Journal, and Genes. Many of these papers tackle important issues in agriculture, biotechnology, and human health.

  4. Strong Collaboration and Networking: His collaborations with international researchers and institutions, as evidenced by his referees and joint projects, reflect his established network within the global scientific community.

  5. Practical Contribution via Next Gen. Solutions (NGS): As the founder of NGS, Dr. Haider has trained over 1,500 researchers, indicating his commitment to the practical application of bioinformatics in Pakistan and beyond. His ability to translate complex bioinformatics concepts into hands-on training is a significant strength.

  6. Cutting-Edge Research Themes: Dr. Haider’s research on RNA-Seq, genome analysis, and machine learning, as well as the application of these techniques to cancer, public health, and agricultural improvements, positions him at the forefront of modern bioinformatics research.

  7. Multidisciplinary Expertise: His ability to apply bioinformatics techniques to diverse areas (e.g., plant genomics, cancer research, disease diagnostics) demonstrates his versatility as a researcher and innovator.

Areas for Improvement:

  1. Visibility and Citation Impact: While Dr. Haider has published extensively, some of his publications might not have achieved as wide a readership or citation count as others. Increasing the visibility of his research through strategic dissemination (e.g., social media engagement, academic platforms) could enhance its impact.

  2. Focus on Recent Advancements: Although Dr. Haider is clearly active in bioinformatics, certain emerging fields, such as AI-driven personalized medicine or novel data analysis techniques, might offer opportunities to expand the scope of his work. Engaging with these newer areas could help to further strengthen his contributions to the field.

  3. Mentorship and Further Collaboration: Despite his significant supervisory role, expanding his mentorship to include more international collaborations could bring fresh perspectives and international recognition to his work. More cross-disciplinary partnerships could lead to innovative breakthroughs.

Education:

Dr. Waseem Haider’s academic journey began with a Master of Computer Science from Arid Agriculture University Rawalpindi in 2008, followed by an M.Sc/M. Phil in Biochemistry and Molecular Biology from Quaid-e-Azam University, Islamabad, in 2002. His pursuit of advanced studies culminated in a Ph.D. in Bioinformatics from the University of Illinois at Urbana-Champaign, USA, in 2014. His educational background has allowed him to bridge the gap between biology, computational sciences, and bioinformatics, shaping his research career. Dr. Haider’s extensive academic foundation enables him to supervise graduate-level research and contribute valuable insights to both the scientific community and industry. His cross-disciplinary expertise supports his role as a mentor, guiding students in bioinformatics, molecular biology, and computational biology, and fostering innovation in these fields.

Experience:

Dr. Waseem Haider has an extensive academic career, serving as a faculty member at COMSATS University Islamabad, Pakistan, since 2005. Before this, he gained experience in college-level teaching, including at Cadet College Hassan Abdal, contributing to a 25-year career in teaching and research. In addition to his academic role, he is the founder and CEO of Next Gen. Solutions (NGS), a company specializing in data analysis training and consultation. Dr. Haider has trained over 1500 researchers in bioinformatics, molecular biology, and computational techniques. His company also conducts workshops and online training sessions, providing critical skills in DNA sequencing, RNA-Seq, and machine learning. With expertise in Linux, Unix, Python, R, and PERL, Dr. Haider has applied computational methods to solve a wide range of biological problems, with his work spanning genomic research, public health, and agricultural improvements.

Research Focus:

Dr. Waseem Haider’s research focuses on applying bioinformatics and computational biology to a variety of biological fields. He specializes in DNA and RNA sequencing technologies, including genome/exome sequencing, RNA-Seq, and metagenomic data analysis. His research also extends to the application of machine learning in cancer genomics, such as RNA-Seq data analysis in cancer, and deep learning techniques in medical imaging. Additionally, Dr. Haider explores genetic variations, particularly in plant biology, and uses transcriptomic data to understand the molecular mechanisms behind disease resistance and stress tolerance in plants like soybean and canola. His work contributes to public health, especially in the analysis of infectious diseases like hepatitis and cystic echinococcosis. He has also made significant contributions to the identification of genetic biomarkers in diseases like breast cancer and diabetes. Through these research endeavors, Dr. Haider is advancing bioinformatics tools and techniques to improve healthcare and agricultural outcomes.

Publications Top Notes: 

  1. Varietal Response of Lycopersicon esculentum L. to Callogenesis and Regeneration 🍅🧬
  2. Functional and Evolutionary Characterization of the CONSTANS Gene Family in Short-Day Photoperiodic Flowering in Soybean 🌱🌾
  3. Newcastle Disease as an Emerging Disease in Peacocks of Tharparker, Pakistan 🦚🦠
  4. Sero-Prevalence of Hepatitis B and C Virus from Rural Areas of Northern Punjab (Sargodha District), Pakistan 🦠💉
  5. Evolutionary Trajectories of Duplicated FT Homologues and Their Roles in Soybean Domestication 🌿🔬
  6. Knowledge, Attitudes, and Practices Related to Cystic Echinococcosis Endemicity in Pakistan 🐑💉
  7. Transcriptome-Enabled Network Inference Revealed the GmCOL1 Feed-Forward Loop and Its Roles in Photoperiodic Flowering of Soybean 🌾🧬
  8. Knowledge, Attitudes & Practices Regarding Rabies Endemicity Among the Community Members, Pakistan 🐕💉
  9. Morpho-Ecological Study of Freshwater Mollusks of Margalla Foothills, Pakistan 🦪🏞️
  10. Protein Quantification and Enzyme Activity Estimation of Pakistani Wheat Landraces 🌾🔬

Conclusion:

Dr. Waseem Haider is undoubtedly a strong candidate for the Best Paper Award. His deep expertise, innovative research, impactful publications, and significant contributions to training researchers make him a leading figure in bioinformatics. While there are opportunities to increase the visibility of his research, his dedication to solving pressing global problems through bioinformatics and molecular biology positions him as a highly deserving candidate for recognition in the scientific community.

Ana Figueiras | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Ana Figueiras | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Ana Figueiras , Faculty of Pharmacy/University of Coimbra , Portugal

Ana Rita Ramalho Figueiras is an Assistant Professor at the Faculty of Pharmacy, University of Coimbra, Portugal, and a researcher at REQUIMTE/LAQV, focusing on Pharmaceutical Technology. She earned her PhD in Pharmaceutics from the University of Coimbra in 2009, specializing in drug delivery systems, particularly for cancer treatments. Throughout her career, Ana has worked on advancing the development of block copolymers and micellar systems for targeted drug delivery. With a strong academic background and international exposure, she has contributed significantly to the fields of pharmaceutics, drug formulation, and pharmaceutical sciences. Ana’s work has been recognized through various publications in top journals, and she is deeply involved in mentoring post-doctoral researchers. Her expertise and leadership in pharmaceutical research continue to influence the development of innovative therapies in the pharmaceutical field.

Publication Profile: 

Orcid

Strengths for the Award:

Ana Rita Ramalho Figueiras is a highly accomplished researcher in pharmaceutical sciences, with extensive contributions to drug delivery systems, particularly focusing on micellar systems and polymeric micelles for cancer therapy. Her interdisciplinary work bridges pharmaceutics, chemistry, and biomedicine, showcasing her ability to innovate within drug delivery mechanisms for complex diseases. As an Assistant Professor at the University of Coimbra and an integrated member of the REQUIMTE/LAQV research group, she brings a wealth of academic and research leadership to her field.

Her innovative contributions have been recognized with various academic awards, including distinctions for oral communications and publications. Additionally, she has made substantial contributions to numerous collaborative research projects, focusing on the development of novel therapeutic strategies and drug delivery systems that target poorly soluble drugs, cancer therapies, and chronic diseases like Alzheimer’s.

Areas for Improvement:

While Figueiras is a leading figure in the scientific community, expanding her outreach to a broader range of international research collaborations could further amplify her impact. Although her work on drug delivery systems has significant potential for clinical applications, there could be further focus on translating her findings from bench to bedside by collaborating with clinical researchers for clinical trials and regulatory studies. A stronger emphasis on commercialization of her research could also be beneficial for broader societal impact.

Education:

Ana Rita Ramalho Figueiras pursued her academic journey in the field of Pharmaceutical Sciences, beginning at the University of Coimbra in Portugal. She graduated with a degree in Pharmaceutical Sciences in 2002, followed by a PhD in Pharmaceutics at the same university in 2009. Her doctoral research was focused on enhancing drug solubility and permeability, with a specific focus on cyclodextrins and mucoadhesive polymers for buccal drug delivery. During her PhD, she gained international exposure by collaborating with the University of Santiago de Compostela, Spain, and the University of Innsbruck, Austria. She is also registered as a member of the Ordem dos Farmacêuticos in Portugal since 2003. Ana’s educational foundation, combined with her interdisciplinary collaborations, has provided her with a robust understanding of pharmaceutical sciences and technologies, forming the cornerstone of her impactful career in academia and research.

Experience:

Ana Rita Ramalho Figueiras has been an Assistant Professor at the Faculty of Pharmacy, University of Coimbra, since September 2014, where she is an integrated Ph.D. member in the Pharmaceutical Technology group of REQUIMTE/LAQV. Prior to this, she was an Invited Assistant Professor from 2013 to 2014, working closely with the Center of Neuroscience and Cell Biology (CNC/UC) and contributing as a collaborator in the Health Sciences Research Centre (CICS/UBI). Her academic roles involve teaching, mentoring students and postdoctoral fellows, and leading research projects on advanced drug delivery systems. She has also been involved in supervising several postdoctoral researchers, focusing on developing and characterizing polymeric micellar systems and controlled delivery systems for drugs like pilocarpine. Throughout her career, Ana has participated in various scientific projects, bringing valuable insights into the design of innovative drug delivery platforms with applications in cancer therapy and other medical conditions.

Awards and Honors:

Ana Rita Ramalho Figueiras has received several accolades for her research excellence and contributions to the field of Pharmaceutical Sciences. In 2004, she was awarded a prestigious PhD fellowship by Fundação para a Ciência e Tecnologia (FCT), which enabled her to pursue her doctoral studies. In 2011, she received the Best Short Communication Award at the VI Annual CICS Symposium for her work on new therapeutic strategies for siRNA delivery. In 2012, she was honored with the Best Oral Communication Award for her research on Poloxamine-α-cyclodextrin supramolecular gels promoting osteogenic differentiation of mesenchymal stem cells. These awards underscore her commitment to scientific advancement, as she continues to lead innovative research in drug delivery systems, nanomedicine, and cancer therapy. Ana’s dedication to advancing pharmaceutics has also led her to mentor future generations of researchers, further solidifying her reputation as a leading academic in her field.

Research Focus:

Ana Rita Ramalho Figueiras focuses her research on developing advanced drug delivery systems, specifically in the context of cancer therapies. Her primary research interest lies in utilizing block copolymers and micellar systems for targeted and controlled drug release. This includes the formulation of poorly water-soluble drugs, improving their bioavailability, and creating novel pharmaceutical formulations for effective treatment. Ana is particularly interested in the development of polymeric micelles for the delivery of therapeutic agents, including drugs and genes, to treat various diseases, with a strong emphasis on oncology. Additionally, her research investigates the use of mucoadhesive polymers for drug delivery to mucosal surfaces. With a commitment to improving drug efficacy and reducing side effects, her work aims to enhance patient outcomes through innovative drug formulations. Ana is also involved in several projects that explore natural compounds and their potential for pharmaceutical applications, further contributing to advancements in the drug delivery and pharmaceutical fields.

Publications Top Notes:

  1. “Unraveling Rosmarinic Acid Anticancer Mechanisms in Oral Cancer Malignant Transformation” 🎗️🦷
  2. “Regulation and Safety of Cosmetics: Pre- and Post-Market Considerations for Adverse Events and Environmental Impacts” 💄⚖️
  3. “The Many Faces of Cyclodextrins within Self-Assembling Polymer Nanovehicles: From Inclusion Complexes to Valuable Structural and Functional Elements” 🔬🧪
  4. “Development and Characterization of Curcumin-Loaded TPGS/F127/P123 Polymeric Micelles as a Potential Therapy for Colorectal Cancer” 🍂⚕️
  5. “Pulmonary Delivery of Bacterial Lysates Mediated by Locust Bean Gum Microparticles” 🌬️🦠
  6. “Non-Toxic Mucoadhesive Locust Bean Gum Microparticles for Delivery of Bacterial Lysates to Prevent Respiratory Diseases” 🌱🫁
  7. “Polymersomes as the Next Attractive Generation of Drug Delivery Systems: Definition, Synthesis and Applications” 🧫💊
  8. “Nanotheranostics: The Afterglow for Cancer Immunotherapy” 💡💉
  9. “Acanthus Mollis Formulations for Transdermal Delivery: From Hydrogels to Emulsions” 🌿💧
  10. “A Review of the Application of Ganoderma Lucidum (Curtis) P. Karst. in Nanotechnology for the Treatment of Cancer” 🍄💻

Conclusion:

Ana Figueiras’ expertise in pharmaceutical technology, particularly in the development of polymeric micelles for drug delivery, marks her as an outstanding candidate for the Best Researcher Award. She is an exemplary figure in the realm of pharmaceutics with a strong research focus on improving drug therapies for cancer and other severe diseases. Her work continues to advance drug delivery systems, paving the way for future medical breakthroughs. Figueiras demonstrates a strong foundation in academic excellence, research innovation, and collaboration, positioning her as a leader in her field.

Soumya Basu | RNA Biology Function | Women Researcher Award

Published on by Cell Biologist

Dr. Soumya Basu | RNA Biology Function | Women Researcher Award

Dr. Soumya Basu , Dr. D. Y. Patil Biotechnology and Bioinformatics Institute , India

Dr. Soumya Basu, an Associate Professor and Principal Investigator at the Cancer and Translational Research Centre, Dr. D.Y. Patil Biotechnology Institute, Pune, boasts 18+ years of experience in life sciences. With a Ph.D. from Jadavpur University and expertise in cell culture, nc-RNA research, small molecule design, and drug-resistant cancer therapy, Dr. Basu is a recognized leader in cancer research. She has contributed extensively to research, scientific writing, and mentoring, with a strong track record in publications, book chapters, and protocols. Her experience spans academic positions, including roles at the Tata Memorial Centre and Chittaranjan National Cancer Institute. Dr. Basu is committed to exploring the molecular mechanisms of cancer and developing innovative therapeutic strategies, with a focus on natural product analogs and drug delivery systems targeting metastatic cancers. Her research continues to impact the understanding and treatment of cancer at a molecular level.

Publication Profile: 

Orcid

Strengths for the Award:

  1. Extensive Research Experience: Dr. Soumya Basu brings over 18 years of research experience in life sciences, with a strong focus on cancer research, small molecule design, nc-RNA research, and drug delivery systems. Her expertise in animal cell culture, cell-based assays, and molecular biology techniques demonstrates her ability to drive impactful research.

  2. Significant Academic Contribution: As a Principal Investigator at the Cancer and Translational Research Centre, Dr. Basu has made notable contributions in the area of targeted cancer therapies. Her involvement in high-impact publications, including recent journal articles and book chapters, highlights her active role in advancing scientific knowledge.

  3. Leadership and Mentorship: As an Associate Professor, Dr. Basu has shown a commitment to leadership, team management, and mentoring students and researchers. Her role as a mentor and ability to manage cross-functional teams demonstrate strong organizational and leadership skills.

  4. Scientific Writing and Publishing: Dr. Basu’s contributions to scientific literature are extensive, with multiple publications in peer-reviewed journals and book chapters. Her work on drug discovery, biomaterials, and the application of AI in drug development further illustrates her versatility and scientific rigor.

  5. Innovative Research Areas: Dr. Basu is involved in cutting-edge research areas, such as the development of natural product analogs targeting the PPAR pathway in lung carcinoma, and the design of drug delivery systems to target metastatic lymph nodes in breast cancer. Her research has the potential for significant clinical impact.

  6. Educational Background: Dr. Basu’s academic qualifications, including a Ph.D. in Life Sciences, an advanced PG course in Artificial Intelligence and Machine Learning, and an advanced diploma in Medical Writing and Regulatory Affairs, showcase her diverse skill set and adaptability to evolving scientific fields.

Areas for Improvement:

  1. Broadening Research Scope: While Dr. Basu’s focus on cancer research and small molecules is impressive, expanding her research into broader therapeutic areas or exploring more interdisciplinary fields could further strengthen her profile as a researcher. Her expertise in AI and machine learning could be leveraged further to address other diseases or health-related issues, potentially opening up new avenues for impactful research.

  2. Increase Collaborative Opportunities: While she has worked with prominent researchers, increasing international collaborations, especially in fields like artificial intelligence in biomedical research, could enhance the global impact of her work and broaden her professional network.

  3. Public Engagement and Outreach: Dr. Basu could focus on increasing public outreach and raising awareness of her research. Given her significant contributions, engaging with non-scientific audiences, through media interviews, science communication platforms, or public talks, could further highlight her as a thought leader.

Education:

Dr. Soumya Basu holds a Ph.D. in Life Sciences from Jadavpur University, where her thesis explored “Reactive oxygen species-mediated targeted therapy in drug-resistant cancer.” She furthered her academic journey with an advanced PG course in Artificial Intelligence and Machine Learning from the University of Texas at Austin, where she earned a 90% score. Dr. Basu also completed an Advanced Diploma in Medical Writing and Regulatory Affairs from Syncorp Educational Institution in Bangalore. She earned her M.Sc. in Microbiology from the University of Kalyani with a 65.6% mark and her B.Sc. (Hons.) in Physics, Chemistry, and Mathematics from the University of Burdwan. Dr. Basu’s educational background showcases a blend of biological sciences and interdisciplinary learning, equipping her with the necessary skills to tackle complex challenges in cancer research and translational medicine.

Experience:

Dr. Soumya Basu has built an illustrious academic and research career. Currently, she is an Associate Professor and Principal Investigator at Dr. D.Y. Patil Biotechnology Institute, Pune, where she has been since 2014. Dr. Basu’s academic journey includes significant roles in research, including her tenure as a Research Associate at the Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai. Her work at Chittaranjan National Cancer Institute, Kolkata, as a Senior Research Fellow (ICMR), honed her skills in cancer biology and cellular chemotherapy. Additionally, she served as a Project Assistant at Jadavpur University and the University of Calcutta, gaining foundational research experience. Her early career also included a position as a Lecturer at Kulti College. Dr. Basu’s multifaceted experience allows her to mentor students, manage cross-functional teams, and spearhead research projects in cancer and drug delivery systems.

Awards and Honors:

Dr. Soumya Basu’s dedication to research excellence has earned her numerous accolades. Her work in cancer research has led to high-impact publications in prestigious journals, with citations exceeding 550 and an H-index of 14. Dr. Basu’s expertise in drug design, nc-RNA research, and cell-based assays has contributed to the development of novel therapeutic approaches in cancer treatment. Her research collaborations have resulted in successful international publications, particularly in drug discovery and cancer genomics. Additionally, she has received recognition from academic and research institutions for her contributions to the field of cancer and biotechnology. Although specific awards are not listed, Dr. Basu’s consistent publication record and leadership in cutting-edge research demonstrate her significant influence in her field. Her recognition among peers and scientific communities highlights her as a key figure in advancing translational medicine and cancer therapy.

Research Focus:

Dr. Soumya Basu’s research primarily focuses on the molecular mechanisms of cancer and the development of innovative therapies. Her work emphasizes the design and synthesis of natural product analogs targeting the PPAR pathway in lung carcinoma and other cancers. Dr. Basu is passionate about advancing drug delivery systems, particularly those targeting metastatic lymph nodes in breast cancer. Her research also delves into non-coding RNAs (ncRNAs), exploring their roles in cancer biology and therapeutic potential. A significant portion of her work is dedicated to studying drug-resistant cancers and designing targeted therapies to overcome resistance. She is involved in both basic and applied research, aiming to develop novel, more effective cancer treatments. Dr. Basu’s interdisciplinary approach integrates artificial intelligence and machine learning techniques with biotechnological applications, positioning her as a forward-thinking scientist at the intersection of computational and experimental cancer research.

Publications Top Notes:

  1. miRVim: Three-dimensional miRNA Structure Database (2024) 🧬📚
  2. Novel insights on oral squamous cell carcinoma management using long non-coding RNAs (2024) 🦷💉
  3. Design, Docking, Synthesis, and In vitro Evaluation of Potent Anti-tubercular Agents Targeting DNA Gyrase (2024) 💊🧪
  4. Identification of Novel PPAR-β/δ Agonists from Kaempferol, Quercetin, and Resveratrol Derivatives by Targeting Cancer (2024) 🍇💥
  5. Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancer (2023) 🌿🔬
  6. Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR‐γ Partial Agonists by Modulating EMT in Lung Cancer (2023) 🍃🫀
  7. Partial Activation of PPAR‐γ by Synthesized Quercetin Derivatives Modulates TGF‐β1‐Induced EMT in Lung Cancer Cells (2023) 💊🧬
  8. Synergistic combination of ritonavir and cisplatin as an efficacious therapy in human cervical cancer cells (2023) 💊🤝
  9. Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications (2023) 💉🧬

Conclusion:

Dr. Soumya Basu is a highly deserving candidate for the Research for Women Researcher Award. Her substantial research contributions, leadership roles, and innovative work in the cancer research field, particularly in drug discovery and therapeutic design, make her a standout candidate. Dr. Basu’s scientific rigor, ability to manage and mentor, and her commitment to advancing medical science position her as a leader in her field. Despite areas for further growth, particularly in expanding the scope of her research and increasing public engagement, Dr. Basu’s exemplary career trajectory, mentorship, and active research contributions make her an outstanding nominee for this prestigious award.

Huifeng Hao | Tumor pharmacology | Best Researcher Award

Published on by Cell Biologist

Dr. Huifeng Hao | Tumor pharmacology | Best Researcher Award

Dr. Huifeng Hao , Peking University Cancer Hospital , China

Dr. Huifeng Hao is an Assistant Investigator at Peking University Cancer Hospital, specializing in the integration of Chinese and Western medicine. He holds a Ph.D. from Peking University Health Science Center, where he explored Chinese-Western medical integration. His research journey began with a Bachelor’s in Clinical Medicine from Hebei Medical University. Dr. Hao has accumulated valuable postdoctoral experience at Peking Union Medical College (PUMC) in Vascular Pharmacology. His work has greatly contributed to the understanding of cancer progression, focusing on the interactions between cancer cells and vascular endothelial cells and the therapeutic effects of Traditional Chinese Medicine. With over a decade of expertise, Dr. Hao has published extensively in renowned journals, addressing critical topics in cancer research, endothelial cell function, and vascular health.

Publication Profile:

Orcid

Strengths for the Award:

  1. Extensive Educational and Research Background: Dr. Huifeng Hao has a comprehensive and solid academic foundation. With a Bachelor’s degree in Clinical Medicine from Hebei Medical University and a Ph.D. in the Integration of Chinese and Western Medicine from Peking University Health Science Center, his educational background is robust. Moreover, his postdoctoral research in Vascular Pharmacology at Peking Union Medical College significantly bolsters his expertise, particularly in vascular biology and its implications in cancer progression.

  2. Groundbreaking Research Areas: Dr. Hao’s research primarily focuses on the complex interactions between cancer cells and vascular endothelial cells, along with exploring how Traditional Chinese Medicine (TCM) can influence cancer progression. This intersection of modern pharmacology and traditional medicine offers a unique and innovative approach to cancer therapy. His studies on cancer metastasis, endothelial cell signaling, and the use of TCM as a potential therapeutic strategy for cancer represent cutting-edge work.

  3. Impressive Publication Record: Dr. Hao has co-authored numerous high-impact publications in leading journals, such as Phytomedicine, Frontiers in Pharmacology, Journal of Ethnopharmacology, and Journal of Cellular and Molecular Medicine. His work spans across critical cancer pathways, pharmacological interventions, and the exploration of novel therapeutic agents like Marsdenia Tenacissima and Berberine in combating metastasis and endothelial dysfunction.

    • His 2022 papers on the modified Bu-Fei decoction’s effects on lung metastasis and the role of CUEDC2 in promoting breast cancer progression are particularly notable for their novel findings and potential clinical applications.

  4. Collaborative and Multi-Disciplinary Research: Dr. Hao’s ability to collaborate with a wide array of experts and researchers in diverse fields demonstrates his interdisciplinary approach to solving complex scientific questions. This collaboration enhances the relevance and applicability of his work in various research areas, particularly in cancer biology, pharmacology, and integrative medicine.

  5. Pioneering Work on TCM in Cancer Therapy: Dr. Hao’s research on the role of Traditional Chinese Medicine (TCM) in cancer therapy is especially noteworthy. His studies examining how TCM influences tumor microenvironments and endothelial cell interactions provide critical insights into how integrative medicine might be leveraged to treat cancer in combination with conventional therapies. This pioneering research has the potential to redefine cancer treatments and offer patients holistic therapeutic options.

  6. Strong Impact on Cancer Research: His work on vascular pharmacology, tumor angiogenesis, and metastasis in lung cancer, particularly through the modulation of transforming growth factor beta receptors and nitric oxide signaling, has significant implications for the development of new cancer therapies. His publications are contributing valuable knowledge toward better understanding cancer progression and discovering more effective treatments.

Areas for Improvement:

  1. Broader Research Scope in Clinical Settings: While Dr. Hao’s research has focused heavily on preclinical studies, including animal models and cellular assays, expanding his research into clinical trials or human-based studies would provide essential validation for his findings. Involving clinical datasets and patient-centered research could strengthen the real-world applicability of his work.

  2. Increase in Independent Research Funding: While Dr. Hao has contributed significantly to various collaborative projects, securing independent research grants would allow him more freedom to explore his unique research hypotheses in greater depth and broaden the scope of his investigations.

  3. Expansion of International Collaborations: While Dr. Hao’s collaborations are impressive, further expanding his international network could provide additional insights and allow him to take his research to the global forefront. Partnerships with leading international cancer research institutions could also amplify the impact of his work.

Education:

  • 2004.09-2009.06: Hebei Medical University (Bachelor Degree in Clinical Medicine)
  • 2009.09-2014.06: Peking University Health Science Center (Ph.D. in Integration of Chinese and Western Medicine)
  • 2014.09-2018.08: Peking Union Medical College (Postdoctoral Training in Vascular Pharmacology)

Dr. Hao’s academic journey spans over a decade of rigorous training, blending Western scientific research with Traditional Chinese Medicine. He received his bachelor’s degree in clinical medicine and later pursued his Ph.D. in an interdisciplinary program that focused on integrating these two approaches to medicine. His postdoctoral research in vascular pharmacology furthered his expertise in understanding the physiological and molecular mechanisms of cancer-related vascular changes.

Experience:

  • 2014.09-2018.08: Postdoctoral Researcher, Peking Union Medical College, Vascular Pharmacology
  • 2018.08-Present: Assistant Investigator, Peking University Cancer Hospital, Integration of Chinese and Western Medicine

Dr. Hao’s research career spans significant academic institutions in China. During his postdoctoral research at PUMC, he specialized in vascular pharmacology, focusing on the molecular pathways involved in tumor vasculature. At Peking University Cancer Hospital, Dr. Hao continues to investigate how traditional medicine can alter the interactions between cancer cells and endothelial cells, with a goal of developing novel therapeutic strategies for cancer treatment. His interdisciplinary approach has led to multiple breakthrough discoveries in cancer biology and integrative medicine.

Research Focus:

Dr. Hao’s primary research areas include:

  • Investigating the interactions between cancer cells and vascular endothelial cells, and how these affect cancer progression
  • Exploring the role of Traditional Chinese Medicine (TCM) in regulating cancer cell interactions within the tumor microenvironment, especially with endothelial cells

By bridging the gap between modern biomedical science and traditional medicine, Dr. Hao aims to develop therapies that utilize both modalities to inhibit tumor growth and metastasis. His work focuses on understanding how TCM can modulate endothelial cells and vascular pathways, potentially leading to new treatments for cancer that are more holistic and effective.

Publications Top Notes:

  1. Modified Bu-Fei decoction inhibits lung metastasis via suppressing angiopoietin-like 4 🫁🦠
  2. CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis 🧬💥
  3. Berberine Suppresses Lung Metastasis of Cancer via Inhibiting Endothelial Transforming Growth Factor Beta Receptor 1 🌱🏥
  4. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF 🌿🧫
  5. The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice 🐭💉
  6. Nitric oxide, a communicator between tumor cells and endothelial cells, mediates the anti-tumor effects of Marsdenia Tenacissima Extract (MTE) 💡🔬
  7. Marsdenia tenacissima extract promotes gefitinib accumulation in tumor tissues of lung cancer xenograft mice via inhibiting ABCG2 activity 💊🔬
  8. Marsdenia tenacissima extract dilated small mesenteric arteries via stimulating endothelial nitric oxide synthase and inhibiting calcium influx 🧪🩸
  9. Protective Role of mPGES-1 (Microsomal Prostaglandin E Synthase-1)-Derived PGE(2) (Prostaglandin E-2) and the Endothelial EP4 (Prostaglandin E Receptor) in Vascular Responses to Injury 💥🩺
  10. Loss of Endothelial CXCR7 Impairs Vascular Homeostasis, and Cardiac Remodeling After Myocardial Infarction ❤️🫀

Conclusion:

Dr. Huifeng Hao’s contributions to cancer research, particularly the intersection of TCM and Western medicine, make him an excellent candidate for the Best Researcher Award. His innovative studies, combined with his dedication to advancing cancer treatment, position him as a leading researcher in his field. His continued research promises to significantly impact both scientific understanding and clinical practices in cancer therapy.

Chao Weng | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Mr. Chao Weng | Immunology Cellular Interactions | Best Researcher Award

Mr. Chao Weng , Renmin Hospital of Wuhan University , China

Dr. Chao Weng is an Associate Chief Physician at Renmin Hospital of Wuhan University. With both an MD and a Ph.D. from Wuhan University, he further advanced his expertise through two years of research at McGill University, Canada. Specializing in neuroimmune diseases, Dr. Weng is proficient in diagnosing and treating conditions such as multiple sclerosis, myasthenia gravis, and Guillain-Barré syndrome. His prolific career spans over 40 published papers, including nearly 20 SCI-indexed articles. Dr. Weng has contributed significantly to scientific research with over nine research projects, including international collaborations, and has been awarded national patents and honors. He is an active member of prominent neurological associations, including the Neurology Branch of the China Association for the Promotion of International Exchange in Healthcare and the Wuhan Electroencephalography and Neurophysiology Association.

Publication Profile:

Orcid

Strengths for the Award:

Dr. Chao Weng is an accomplished researcher and clinician, demonstrating significant contributions to the field of neuroimmune diseases, particularly multiple sclerosis, myasthenia gravis, and Guillain-Barré syndrome. His expertise in molecular mechanisms, particularly in myelin development and regeneration, is groundbreaking, as reflected in his research projects funded by prestigious organizations such as the National Natural Science Foundation of China and the Multiple Sclerosis Society of Canada. He has published over 40 academic papers, including nearly 20 SCI papers, and is actively involved in high-impact research on transcription factors, gene mutations, and the pathogenesis of various neurological conditions. His work on promoting oligodendrocyte differentiation and remyelination is highly relevant to advancing treatments for neuroimmune diseases.

In addition to his strong publication record, Dr. Weng’s leadership in hosting and participating in multiple scientific research projects, alongside his involvement in clinical education and professional organizations, demonstrates his multifaceted impact on the field. His contributions have been recognized with awards such as the second prize for scientific and technological progress in Hubei Province and a national invention patent. Furthermore, his collaborations with prestigious institutions like McGill University enhance the international scope of his work.

Areas for Improvement:

Although Dr. Weng’s research achievements are significant, continued engagement with broader interdisciplinary collaborations could further enhance the impact of his work. Integrating new technologies or methodologies in neuroimmune disease diagnostics and treatment, such as artificial intelligence or advanced imaging techniques, could provide additional depth to his ongoing projects. Furthermore, further outreach through mentorship of younger researchers could help cultivate the next generation of scientists and clinicians in his area of expertise. Expanding industry collaborations could also provide more avenues for the translation of research into clinical practice.

Education:

Dr. Chao Weng completed his MD and Ph.D. at Wuhan University, where he focused on neuroimmune diseases. Afterward, he expanded his knowledge by studying abroad at McGill University in Canada for two years. His education provided him with a strong foundation in both clinical practice and research in neuroimmunology, especially related to diseases like multiple sclerosis, myasthenia gravis, and Guillain-Barré syndrome. At Wuhan University, Dr. Weng honed his expertise in molecular mechanisms of neuroimmune diseases and remyelination. His ongoing commitment to furthering scientific research in neurology and neuroimmunology has kept him at the forefront of cutting-edge advancements in his field, including in vitro human and mouse oligodendrocyte culture and transcription factor Tcf7l2’s role in oligodendrocyte differentiation.

Experience:

Dr. Chao Weng has extensive experience in the clinical diagnosis and treatment of neuroimmune diseases, particularly focusing on conditions like multiple sclerosis, myasthenia gravis, and Guillain-Barré syndrome. Over the years, he has been actively involved in scientific research, completing and overseeing numerous research projects. He has led nine major scientific research projects, including collaborations with international research institutions like McGill University, Canada. Dr. Weng has published over 40 academic papers, including 20 SCI papers, contributing to the understanding of neuroimmune diseases, myelin repair, and neurodegeneration. His involvement in high-impact research, such as studying transcription factors for oligodendrocyte differentiation and remyelination, and investigating molecular mechanisms in neurological diseases, demonstrates his dedication to advancing both basic and clinical research. Additionally, he is a respected member of various neurological organizations and has received significant recognition for his scientific achievements.

Awards and Honors:

Dr. Chao Weng has earned numerous accolades for his scientific contributions, including a second prize for scientific and technological progress in Hubei Province. His groundbreaking research in neuroimmune diseases and oligodendrocyte differentiation has garnered recognition in the academic community, where he has published more than 40 peer-reviewed papers, nearly 20 of them indexed in SCI. Dr. Weng has also been awarded a national invention patent, underscoring his innovative contributions to medical science. His commitment to advancing medical knowledge and improving patient outcomes in neuroimmune diseases has positioned him as a leader in his field. His recognition extends to his role as a director of the Wuhan Electroencephalography and Neurophysiology Association and a member of the Neurology Branch of the China Association for the Promotion of International Exchange in Healthcare, which further highlights his influence and standing in the scientific and medical community.

Research Focus:

Dr. Chao Weng’s primary research focus lies in neuroimmune diseases, specifically exploring the molecular mechanisms underlying diseases like multiple sclerosis, myasthenia gravis, and Guillain-Barré syndrome. His work emphasizes remyelination, the repair of myelin in neurodegenerative diseases, and the role of oligodendrocyte differentiation in central nervous system regeneration. He has spent nearly a decade investigating transcription factor Tcf7l2’s impact on myelin development and regeneration. Dr. Weng has also made significant contributions to understanding the role of β-arrestin 2 in protecting against neurological defects induced by viral infections such as herpes simplex encephalitis. Additionally, his research covers the therapeutic potential of neurotrophic factors and ion channels in various neurological disorders, including Parkinson’s disease and epilepsy. Through his work, Dr. Weng has become a key figure in bridging basic neuroscience with clinical applications, aiming to enhance diagnostic and therapeutic strategies for patients suffering from neuroimmune conditions.

Publications Top Notes:

  1. Transcription factor 7 like 2 promotes oligodendrocyte differentiation and remyelination 🧠
  2. Screening Gene Mutations in Chinese Patients With Benign Essential Blepharospasm 🔬
  3. β-Arrestin 2 protects against neurological function defects in HSV-1-induced encephalitis mice 🦠
  4. Inhibition of Acid Sensing Ion Channel 3 Aggravates Seizures by Regulating NMDAR Function ⚡
  5. Purkinje Cell Degeneration and Motor Coordination Deficits in a New Mouse Model of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay 🧑‍🔬
  6. Ankfy1 is dispensable for neural stem/precursor cell development 🧬
  7. Clinical and electrophysiological evaluation of neutral wrist nocturnal splinting in patients with carpal tunnel syndrome 🤕
  8. Ring finger sensory latency difference in the diagnosis and treatment of carpal tunnel syndrome 💡
  9. Multiple and short-range cross-linking of dialdehyde carboxymethyl cellulose contributes to regulating the physicochemical property of collagen fibril 🔗
  10. Chronic inflammatory demyelinating polyneuropathy and psoriasis comorbidity with significantly alleviated symptoms after secukinumab 💊

Conclusion:

Dr. Chao Weng is undoubtedly a strong candidate for the Best Researcher Award. His consistent dedication to advancing the understanding of neuroimmune diseases, coupled with his significant contributions to the molecular mechanisms of myelin repair and regeneration, positions him as an exceptional researcher. His multidisciplinary research approach, coupled with his numerous publications and scientific innovations, speaks to his outstanding capability in the field. With continued growth in interdisciplinary collaboration and industry partnerships, Dr. Weng is well-placed to continue making profound contributions to neurology and neuroimmune disease treatments.

Hadji Djebar | Microbial Cell Biology | Best Paper Award

Published on by Cell Biologist

Prof. Hadji Djebar | Microbial Cell Biology | Best Paper Award

Prof. Hadji Djebar , saida university ,  Algeria

Dr. Djebar Hadji is a professor at Saida University, Algeria, specializing in nonlinear optical (NLO) properties, structural analysis, and theoretical quantum chemistry methods. With a deep passion for material science, his research focuses on the relationship between molecular structure and its photonic and NLO properties. Dr. Hadji has published numerous articles in top-tier scientific journals and is a recognized expert in computational chemistry, particularly within the field of nonlinear optics. His contributions extend to being an editor for BMC Chemistry, Springer, and a referee for several journals in his field. He has demonstrated significant expertise in the theoretical investigation of novel materials, combining both experimental and theoretical approaches. Dr. Hadji is continuously working on advancing the understanding of nonlinear optical properties in various molecular compounds and materials.

Publication Profile: 

Orcid

Strengths for the Award:

Dr. Djebar Hadji’s work is well-regarded in the field of Nonlinear Optical (NLO) properties, with a focus on theoretical quantum chemistry and structure-property relationships. His substantial body of work published in high-impact journals like Journal of Molecular Liquids, Journal of Electronic Materials, and Revue Roumaine de Chimie highlights his expertise in the synthesis, characterization, and theoretical study of NLO materials. Dr. Hadji’s research makes a notable contribution to understanding the photonic behavior and NLO properties of various chemical compounds, from organic to inorganic hybrids. His work on N-acyl glycine derivatives and thiosemicarbazides stands out for their novel approaches and interdisciplinary nature. Theoretical methodologies, alongside experimental validations, provide a well-rounded understanding of the materials under study. Furthermore, his continuous engagement as a reviewer and editor adds to his credibility in the scientific community.

Areas for Improvement:

While Dr. Hadji’s research has covered a broad spectrum of NLO materials, there appears to be room to increase the scope of applications and practical validations of these materials in real-world scenarios. A more applied focus, such as exploring their use in specific devices or industry-related innovations, could be beneficial for the impact and commercial potential of his work. Additionally, expanding collaborative efforts with experimentalists in material fabrication could lead to more direct applications and enhance the relevance of the research.

Education:

Dr. Djebar Hadji completed his academic journey with distinction in the field of chemistry. He earned his Ph.D. in Chemistry from a renowned Algerian institution, focusing on nonlinear optical properties and theoretical quantum chemistry methods. His academic endeavors have led him to explore various facets of computational chemistry, and he has continued to deepen his knowledge and expertise throughout his career. Dr. Hadji’s education has provided him with a robust foundation in both theoretical and experimental aspects of chemistry, which has fueled his research on understanding the complex relationships between molecular structures and their properties. His postgraduate education was complemented by ongoing professional development, where he has continuously engaged with the global scientific community through collaborations, conferences, and publications. This educational background, combined with years of teaching and research experience, has made Dr. Hadji a respected figure in his field.

Experience:

Dr. Djebar Hadji has extensive experience in academia and research. As a professor at Saida University, Dr. Hadji has mentored numerous students, guiding them through the complexities of chemistry and computational modeling. His teaching covers a wide range of topics, including theoretical quantum chemistry and nonlinear optics. Dr. Hadji is actively involved in collaborative research, having contributed to groundbreaking studies published in reputable journals such as Journal of Molecular Liquids, Journal of Electronic Materials, and Physical Chemistry Research. His research spans the theoretical and computational investigation of nonlinear optical properties, focusing on the structure-property relationships in various chemical compounds. Dr. Hadji also holds editorial roles in prominent journals and reviews papers for several renowned scientific publications. His multifaceted experience, including both theoretical and experimental work, positions him as a highly knowledgeable and influential figure in the field of chemistry, particularly in nonlinear optics and material science.

Research Focus:

Dr. Djebar Hadji’s research primarily focuses on nonlinear optical (NLO) properties, the interaction between molecular structures and photonic characteristics, and the application of theoretical quantum chemistry methods. His work investigates how molecular arrangements and electronic properties influence NLO responses, which has vast applications in areas like telecommunications, photonics, and material science. Dr. Hadji’s research explores novel molecular compounds, particularly those with potential for high-performance NLO behavior. He utilizes quantum chemical methods such as DFT (Density Functional Theory) and TD-DFT (Time-Dependent DFT) to predict and analyze molecular properties. Additionally, Dr. Hadji is dedicated to the synthesis and characterization of new materials, including hybrid inorganic-organic systems and azo derivatives. His goal is to design materials with enhanced NLO properties for various technological applications, focusing on optimizing the relationship between structure and function. This research contributes significantly to the development of advanced materials with improved nonlinear optical responses.

Publications Top Notes:

  1. Nonlinear optical and antimicrobial activity of N-acyl glycine derivatives, Journal of Molecular Liquids, 2024 📖🧬
  2. Deeper Insights on the Nonlinear Optical Properties of O-acylated Pyrazoles, Journal of Electronic Materials, 2024 🔬💡
  3. Synthesis And Characterization Of Novel Thiosemicarbazide For Nonlinear Optical Applications: Combined Experimental And Theoretical Study, Revue Roumaine de Chimie, 2024 🔬⚗️
  4. NLO azo compounds with sulfonamide groups: A theoretical investigation, Journal of Indian Chem. Soc., 2023 🧪✨
  5. Synthesis and characterization of novel thiosemicarbazide for nonlinear optical applications, Rev. Roum. Chim., 2023 ⚗️🔍
  6. Efficient NLO Materials Based on Poly(ortho-anisidine) and Polyaniline: A Quantum Chemical Study, Journal of Electronic Materials, 2022 🧬💡
  7. Molecular Structure, Linear, and Nonlinear Optical Properties of Piperazine-1,4-Diium Bis 2,4,6-Trinitrophenolate, Physical Chemistry Research, 2022 ⚗️📚
  8. Theoretical insights into the nonlinear optical properties of cyclotriphosphazene, Journal of Materials Science, 2022 📊🔬
  9. Linear and nonlinear optical properties of anhydride derivatives: A theoretical investigation, December 2021 🧪💡
  10. Synthesis, spectroscopic characterization, crystal structure, and linear/NLO properties of a new hybrid compound, Journal of Molecular Structure, 2021 🧪🔍

Conclusion:

Dr. Djebar Hadji’s extensive contribution to the understanding of nonlinear optical properties of various compounds places him as a strong candidate for the Research for Best Paper Award. His solid foundation in both experimental and theoretical aspects of material science and quantum chemistry, as well as his consistent publication record, are commendable. While his work is theoretically rich, adding practical application studies could further enhance his impact and lead to real-world implementation of his discoveries in the field of optics and photonics.